DeLauro Presses Hamburg On FDA’s Reagan-Udall Funding
This article was originally published in The Tan Sheet
Executive Summary
No funds have been transferred to the foundation and no decision has been made about how much, FDA Commissioner Hamburg says, but DeLauro asks why Reagan-Udall should receive guaranteed funds, when other foundations and nonprofits have to compete.
You may also be interested in...
Appropriators Suggest Moving Food Safety Out Of FDA, Question User Fee Proposals
A House Appropriations Agriculture/FDA subcommittee member suggests splitting food authorities out of FDA to sharpen its pharma and device focus and allow USDA to handle food safety enforcement. Chairman Kingston praises the budget request’s restraint, but members question proposed user fees.
When Reagan-Udall Foundation Gets Started, Funding Is First On To-Do List
The FDA Amendments Act created an abundance of oversight functions to organize in the broad new powers it authorized to FDA for ensuring drug safety, but the act also provides the agency with an outside partner - the Reagan-Udall Foundation
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.